Mark Douglas Smith Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Mark Douglas Smith is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 9,135 shares of JAZZ, which is worth approximately $1.12 Million. The most recent transaction as insider was on Aug 06, 2024, when has been sold 1,484 shares (Ordinary Shares) at a price of $111.35 per share, resulting in proceeds of $165,243. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.14K

0% 3M change

32.62% 12M change

Total Value Held $1.12 Million

Mark Douglas Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 06 2024	SELL Payment of exercise price or tax liability	$165,243 $111.35 p/Share	1,484 Reduced 13.97%	9,135 Ordinary Shares
Aug 02 2024	BUY Grant, award, or other acquisition	-	3,731 Added 26.0%	10,619 Ordinary Shares
Dec 04 2023	SELL Open market or private sale	$49,735 $119.27 p/Share	417 Reduced 5.71%	6,888 Ordinary Shares
Aug 14 2023	SELL Open market or private sale	$171,456 $138.16 p/Share	1,241 Reduced 14.52%	7,305 Ordinary Shares
Aug 11 2023	BUY Grant, award, or other acquisition	-	3,075 Added 26.46%	8,546 Ordinary Shares
Dec 02 2022	SELL Open market or private sale	$64,965 $154.68 p/Share	420 Reduced 7.13%	5,471 Ordinary Shares
Aug 08 2022	SELL Open market or private sale	$165,876 $152.32 p/Share	1,089 Reduced 15.6%	5,891 Ordinary Shares
Aug 05 2022	BUY Grant, award, or other acquisition	-	2,561 Added 26.84%	6,980 Ordinary Shares
Dec 02 2021	SELL Open market or private sale	$50,582 $121.3 p/Share	417 Reduced 8.62%	4,419 Ordinary Shares
Jul 29 2021	BUY Grant, award, or other acquisition	-	2,246 Added 31.71%	4,836 Ordinary Shares
Feb 25 2021	BUY Grant, award, or other acquisition	-	2,590 Added 50.0%	2,590 Ordinary Shares

Also insider at

PHR

Phreesia, Inc. Healthcare

Director

TDOC

Teladoc Health, Inc. Healthcare

Director

MDS